Xcell Biosciences Revenue and Competitors

Location

#5691

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Xcell Biosciences's estimated annual revenue is currently $6.2M per year.(i)
  • Xcell Biosciences's estimated revenue per employee is $155,000

Employee Data

  • Xcell Biosciences has 40 Employees.(i)
  • Xcell Biosciences grew their employee count by 25% last year.

Xcell Biosciences's People

NameTitleEmail/Phone
1
CEO / FounderReveal Email/Phone
2
VP EngineeringReveal Email/Phone
3
Head Application DevelopmentReveal Email/Phone
4
Associate Director, Product ManagementReveal Email/Phone
5
Director OperationsReveal Email/Phone
6
Chief Technology OfficerReveal Email/Phone
7
Chief Scientific OfficerReveal Email/Phone
8
Director Product EngineeringReveal Email/Phone
9
Office Operations ManagerReveal Email/Phone
10
Mechanical Design EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Xcell Biosciences?

Xcell Bio is a San Francisco-based life science company dedicated to bringing an innovative primary cell control solution to the immunotherapy market to support research, drug discovery, and cell manufacturing. Xcell's mission is to democratize maintenance, expansion and control of any primary cell type through its bench-top primary cell control systems, reagent kits, software, and standardized protocols. The technology delivers simple control of primary cell types from blood or solid tissue, including a range of immune cells, stem cells, and tumor cells. This patient-centric technology offers a unique and proprietary capability to improve immunotherapy efficacy, safety, and persistence through more predictive and iterative therapy development and rapid, highly-controlled clinical cell manufacturing. For more information, please visit http://www.xcellbio.com/.

keywords:N/A

N/A

Total Funding

40

Number of Employees

$6.2M

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Xcell Biosciences News

2022-04-17 - Labcorp is teaming up with Xcell to expedite CGT development

The diagnostics and drug development company, Labcorp, is partnering with San Francisco based, Xcell Biosciences, to advance efforts to help...

2022-04-13 - Labcorp Enhances Cell and Gene Therapy Development Support Through Collaboration With Xcell Biosciences

... is collaborating with Xcell Biosciences, Inc. (Xcellbio), a leading developer of cell and gene therapy technologies, to advance critical...

2022-04-13 - Labcorp and Xcell partner to advance cell and gene therapy ...

Credit: Laboratory Corporation of America Holdings. Labcorp has announced collaboration with Xcell Biosciences to progress activities that would...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.2M4090%$14.5M
#2
$4.4M40-5%$60M
#3
$7.5M405%N/A
#4
$4.5M40-76%N/A
#5
$8.1M40N/AN/A